Topics

CNS Tumors | Treatment | Off-label Medications | Memantine

Home > Publications > Topics > CNS Tumors > Treatment > Off-label Medications > Memantine

Gupta T, Dasgupta A, Goswami S, Chatterjee A, Dhingra S, Deodhar J, Sonkusare L, Prasad M, Gollamudi VRM, Kannan S, Vishwakarma K, Menon N, Moiyadi A, Shetty P, Singh V, Epari S, Sahay A, Shah A, Sahu A, Choudhari A, Bhattacharya K, Bano N, Gupta N, Chinnaswamy G.
Memantine to preserve memory and neurocognition following craniospinal irradiation (MEMENTO): a phase 3 randomized controlled trial.
BMC Cancer. 2026 Feb 11;26(1):365. doi: 10.1186/s12885-026-15627-w. PMID: 41673604. Interventional study protocol. ˍ